INMUNOGLOBULINA ANTI D PDF

Aims: To review our experience of anti-D immunoglobulin for immune thrombocytopenia ITP in patients with primary antibody deficiency. Patients were refractory to steroids and high dose intravenous immunoglobulin IVIG. Two patients were previously splenectomised. Results: All patients responded to anti-D immunoglobulin. Improved platelet counts were sustained for at least three months. Side effects included a fall in haemoglobin in all cases; one patient required red blood cell transfusion.

Author:Grogis Mezishakar
Country:Singapore
Language:English (Spanish)
Genre:Photos
Published (Last):9 February 2018
Pages:431
PDF File Size:13.22 Mb
ePub File Size:13.64 Mb
ISBN:609-4-17591-791-4
Downloads:67120
Price:Free* [*Free Regsitration Required]
Uploader:Mikarr



Jump to navigation. Women whose blood group is Rh-negative sometimes form Rh-antibodies when carrying a Rh-positive baby, in response to the baby's different red blood cell make-up. This sensitisation is more likely to happen during birth, but occasionally occurs in late pregnancy. These antibodies can cause anaemia, and sometimes death, for a Rh-positive baby in a subsequent pregnancy.

Giving the mother anti-D after the first birth is known to reduce this problem. This review assessed two trials with moderate to high risk of bias and found that giving anti-D during pregnancy may help as well, although more research is required to confirm these possible benefits and identify any possible harms. Existing studies do not provide conclusive evidence that the use of anti-D during pregnancy benefits either mother or baby in terms of incidence of Rhesus D alloimmunisation during the pregnancy or postpartum, or the incidence of neonatal morbidity jaundice low to very low quality evidence.

However women receiving anti-D may be less likely to register a positive Kleihauer test in pregnancy and at the birth of a Rh-positive infant low quality evidence. Fewer women who receive anti-D during pregnancy may have Rhesus D antibodies in a subsequent pregnancy, with benefits for the baby, however this needs to be tested in studies of robust design.

During pregnancy, a Rhesus negative Rh-negative woman may develop antibodies when her fetus is Rhesus positive Rh-positive. These antibodies may harm Rh-positive babies. To assess the effects of antenatal anti-D immunoglobulin on the incidence of Rhesus D alloimmunisation when given to Rh-negative women without anti-D antibodies. Randomised trials in Rh-negative women without anti-D antibodies given anti-D after 28 weeks of pregnancy, compared with no treatment, placebo or a different regimen of anti-D.

Two review authors independently assessed trials for inclusion and risk of bias , extracted data and checked them for accuracy. We included two trials involving over women, comparing anti-D prophylaxis with no anti-D during pregnancy in this review. Overall, the trials were judged to be at moderate to high risk of bias. In regards to primary review outcomes, there did not appear to be a clear difference in the risks of immunisation when women who received anti-D at 28 and 34 weeks' gestation were compared with women who were not given antenatal anti-D: risk ratio RR for incidence of Rhesus D alloimmunisation during pregnancy was 0.

Neither of the trials reported on incidence of Rhesus D alloimmunisation in subsequent pregnancies. Considering secondary outcomes, in one trial , women receiving anti-D during pregnancy were shown to be less likely to register a positive Kleihauer test which detects fetal cells in maternal blood in pregnancy at 32 to 25 weeks RR 0.

No clear differences were seen for neonatal jaundice RR 0. Neither of the trials reported on adverse effects associated with anti-D treatment.

Authors' conclusions:. Search strategy:. Selection criteria:. Data collection and analysis:. Main results:. You may also be interested in: Anti-D administration after childbirth for preventing Rhesus alloimmunisation Anti-D administration after spontaneous miscarriage for preventing Rhesus alloimmunisation Intramuscular versus intravenous anti-D for preventing Rhesus alloimmunization during pregnancy Techniques of intrauterine fetal transfusion for women with red-cell isoimmunisation for improving health outcomes Antenatal immunoglobulin for fetal red blood cell alloimmunization.

Health topics:. Don't show again. What role do you identify with the most? Patient or care giver. We are collecting information on visitors to our website to ensure Cochrane resources meet the needs of our users.

Your data will be anonymised for processing, will be stored securely, and will not be shared with any third parties.

ENTERPRISE APPLICATION INTEGRATION BY DAVID S LINTHICUM PDF

Inmunoglobulina Anti-D RHO 100mcg Quimbiotec

Common side effects include fever , headache, pain at the site of injection, and red blood cell breakdown. Rh o D immune globulin came into medical use in the s. In a pregnancy where the mother is RhD negative and the father is RhD positive, the probability of the fetus having RhD positive blood is dependent on whether the father is homozygous for RhD i. If the father is homozygous, the fetus will necessarily be RhD positive, as the father will necessarily pass on a Rh D positive allele. If a fetus is RhD positive and the mother is RhD negative, the mother is at risk of RhD alloimmunization, where the mother mounts an immune response develops antibodies to fetal red blood cells.

ISO 27955 PDF

Anti-D Immunoglobulin, Human

Anti-D is a polyclonal IgG product purified from the plasma of D-alloimmunized individuals. The mechanism of anti-D has not been fully elucidated. Antigenic epitopes are not fully masked by anti-D and are available for immune system recognition. However, a correlation has frequently been observed between anti-D-mediated RBC clearance and prevention of the antibody response, suggesting that anti-D may be able to destroy RBCs without triggering the adaptive immune response. The ability of antigen-specific IgG to inhibit antibody responses has also been observed in a variety of animal models immunized with a vast array of different antigens, such as sheep RBCs SRBC. This effect has been referred to as antibody-mediated immune suppression AMIS. In animal models, IgG inhibits the antibody response, but the T-cell response and memory may still be intact.

EUMEX 800V BEDIENUNGSANLEITUNG PDF

Mechanisms of anti-D Action in the Prevention of Hemolytic Disease of the Fetus and Newborn

Jump to navigation. Women whose blood group is Rh-negative sometimes form Rh-antibodies when carrying a Rh-positive baby, in response to the baby's different red blood cell make-up. This sensitisation is more likely to happen during birth, but occasionally occurs in late pregnancy. These antibodies can cause anaemia, and sometimes death, for a Rh-positive baby in a subsequent pregnancy. Giving the mother anti-D after the first birth is known to reduce this problem. This review assessed two trials with moderate to high risk of bias and found that giving anti-D during pregnancy may help as well, although more research is required to confirm these possible benefits and identify any possible harms. Existing studies do not provide conclusive evidence that the use of anti-D during pregnancy benefits either mother or baby in terms of incidence of Rhesus D alloimmunisation during the pregnancy or postpartum, or the incidence of neonatal morbidity jaundice low to very low quality evidence.

Related Articles